Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent cliff. The pharmaceutical leader has made an agreement to acquire the COPD ...
Sept 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved a new formulation of Merck's (MRK.N), opens new tab blockbuster cancer therapy Keytruda that can be ...
Earlier this week, Merck MRK announced a definitive agreement to acquire Verona Pharma VRNA for approximately $10 billion. The deal will add Verona’s Ohtuvayre, approved for the maintenance treatment ...
In the late 1990s, the FDA expressed concerns regarding the diminishing potency of Merck & Co., Inc.’s (NYSE:MRK) mumps vaccine as it neared its shelf life. To address these issues, Merck increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback